1. Stepensky D, Friedman M, Srour W, Raz I, Hoffman A. Preclinical evaluation of pharmacokinetic–pharmacodynamic rationale for oral CR metformin formulation. J Control Release. 2001;71:107–15.
2. Physicians. New Jersey: Desk Reference, Inc., Medical Economics Company; 2003, vol. 57.
3. The Merck Index. Published on CD by Chapman & Hall CRC. Whitehouse Station: Merck & Co Inc, Monograph No. 6001; 1999.
4. Damico C. Nursing, drug handbook. 22nd ed. Springhouse: Springhouse Publishers; 2002. p. 779.
5. Bailey CJ. The anti-hyperglycemic action of metformin. In: Krans HMJ, editor. Diabetes and metformin: a research and clinical update. Royal Society of Medicine international congress and symposium series, No. 79. London: Royal Society of Medicine; 1985. p. 17–26.